Skip to content
Screener

Eikon Therapeutics, Inc. EIKN Prepaid & Other Current

Prepaid & Other Current at other companies

Gilead Sciences logo
Gilead SciencesGILD
$3.76B+29.7%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$18.35M+19.4%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$9.5M+42.8%
OnKure Therapeutics, Inc. logo
OnKure Therapeutics, Inc.OKUR
$5.38M+256%
Immunome logo
ImmunomeIMNM
$18.45M+96.4%
Erasca, Inc. logo
Erasca, Inc.ERAS
$10M-0.4%

Other financials

Income statement

See full
Operating income-$87.3M-22.3%
Net income-$83.0M-21.6%
EPS (diluted)-$2.46+90.9%

Balance sheet

See full
Cash & equivalents$161.2M-21.2%
Total debt$254.8M—
Total equity$550.7M+186%
Total assets$850.8M—

Cash flow

See full
Operating cash flow-$89.8M-64.7%
CapEx$262.0K-98.8%
Free cash flow-$90.1M-17.1%

Valuation

See full
Market cap$502.95M-35.7%
Enterprise value$596.62M—

Returns & leverage

See full
Debt / equity0.5×—
Current ratio11.8×—

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Eikon Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216791

FAQ

What is Eikon Therapeutics, Inc.'s prepaid & other current?
Eikon Therapeutics, Inc. (EIKN) reported prepaid & other current of $16.92M in Q1 2026.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Eikon Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude